BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12925383)

  • 21. Livedoid vasculopathy.
    Chang D; Patel RM
    Cutis; 2012 Oct; 90(4):179, 181-2. PubMed ID: 23259203
    [No Abstract]   [Full Text] [Related]  

  • 22. Skin reactions due to low molecular weight heparin in pregnancy: a strategic dilemma.
    Verdonkschot AE; Vasmel WL; Middeldorp S; van der Schoot JT
    Arch Gynecol Obstet; 2005 Feb; 271(2):163-5. PubMed ID: 15112083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients.
    Poyrazoglu OK; Dogukan A; Yalniz M; Seckin D; Gunal AL
    Ren Fail; 2006; 28(8):723-7. PubMed ID: 17162433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A clinical approach to the vasculitis patient in the dermatologic office.
    Callen JP
    Clin Dermatol; 1999; 17(5):549-53. PubMed ID: 10590847
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunoglobulin G4-related disease associated with cutaneous vasculitis.
    Kawakami T; Yamaguchi N; Soma Y; Yokoyama K; Shirai S; Kimura K
    Acta Derm Venereol; 2014 May; 94(3):327-8. PubMed ID: 24096856
    [No Abstract]   [Full Text] [Related]  

  • 26. [Livedoid vasculopathy with heterozygous factor V Leiden mutation and sticky platelet syndrome].
    Lewerenz V; Burchardt T; Büchau A; Ruzicka T; Megahed M
    Hautarzt; 2004 Apr; 55(4):379-81. PubMed ID: 15021932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case of livedoid vasculopathy with peripheral neuropathy successfully treated with low-dose warfarin.
    Osada S; Kimura Y; Kawana S
    J Dermatol; 2010 Jan; 37(1):98-101. PubMed ID: 20175830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Livedo vasculitis].
    Zecević RD
    Vojnosanit Pregl; 2001; 58(3):263-6. PubMed ID: 11548552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Low-molecular-weight heparins versus unfractionated heparin for treatment of hemodialysed patients].
    Kes P; Basić-Jukić N; Jurić I
    Lijec Vjesn; 2007; 129(8-9):305-8. PubMed ID: 18198633
    [No Abstract]   [Full Text] [Related]  

  • 30. [Low molecular weight heparin in acute coronary syndromes].
    Amit G; Weiss AT; Zagher D
    Harefuah; 1999 Sep; 137(5-6):224-8. PubMed ID: 10959327
    [No Abstract]   [Full Text] [Related]  

  • 31. [The treatment with low-molecular-weight heparin of disseminated intravascular coagulation secondary to an aortic aneurysm].
    Callejas Rubio JL; Ortego Centeno N; Díez Ruiz A; Bermúdez García JM
    Rev Clin Esp; 1998 Nov; 198(11):781-2. PubMed ID: 9883061
    [No Abstract]   [Full Text] [Related]  

  • 32. Livedoid vasculitis. Response to low-dose danazol.
    Hsiao GH; Chiu HC
    Arch Dermatol; 1996 Jul; 132(7):749-51. PubMed ID: 8678566
    [No Abstract]   [Full Text] [Related]  

  • 33. Heterozygous prothrombin G20210A gene mutation in a patient with livedoid vasculitis.
    Gotlib J; Kohler S; Reicherter P; Oro AE; Zehnder JL
    Arch Dermatol; 2003 Aug; 139(8):1081-3. PubMed ID: 12925402
    [No Abstract]   [Full Text] [Related]  

  • 34. Refractory livedoid vasculitis responding to PUVA: a report of four cases.
    Tuchinda C; Leenutaphong V; Sudtim S; Lim HW
    Photodermatol Photoimmunol Photomed; 2005 Jun; 21(3):154-6. PubMed ID: 15888134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Refractory cutaneous necrotizing vasculitis. Successful sulfone therapy].
    Seybold H; Simon M; Schuler G; Lüftl M
    Hautarzt; 2006 Jan; 57(1):47-50. PubMed ID: 15662534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is unfractionated heparin equivalent to low-molecular-weight heparin for venous thromboembolism?
    Graber MA; Dachs R; Darby-Stewart A
    Am Fam Physician; 2008 Jun; 77(11):1492-3. PubMed ID: 18581828
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pulmonary embolism: subcutaneous treatment with low-molecular-weight heparin?].
    Markart P
    Pneumologie; 2004 Nov; 58(11):767-8. PubMed ID: 15534771
    [No Abstract]   [Full Text] [Related]  

  • 38. Low molecular weight heparin (dalteparin) is equally effective as unfractionated heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism.
    Schutgens RE; Esseboom EU; Snijder RJ; Haas FJ; Verzijlbergen F; Nieuwenhuis HK; Lisman T; Biesma DH
    J Lab Clin Med; 2004 Aug; 144(2):100-7. PubMed ID: 15322504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful pregnancy outcome in women with bad obstetric history and recurrent fetal loss due to thrombophilia: effect of unfractionated heparin and low-molecular weight heparin.
    Ghosh K; Shetty S; Vora S; Salvi V
    Clin Appl Thromb Hemost; 2008 Apr; 14(2):174-9. PubMed ID: 18160603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low molecular weight heparin treatment decreases MMP-9 plasma activity in patients with abdominal aortic aneurysm.
    Grzela T; Brawura-Biskupski-Samaha R; Jelenska MM; Szmidt J
    Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):159-61. PubMed ID: 17964826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.